Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis
Yuta Nakai(NOF Corporation (Japan)), Hiroshi Takayanagi(The University of Tokyo)
Cited by 104
Related Papers
Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation
|Genes & Development|2003|281
The neutrophil–osteogenic cell axis promotes bone destruction in periodontitis
|International Journal of Oral Science|2024|57
Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B–mediated vesicle transport
|Journal of Bone and Mineral Research|2012|38
Identification of an intronic enhancer regulating RANKL expression in osteocytic cells
|Bone Research|2023|24